- IN₹1.01bn
- IN₹998.41m
- IN₹337.22m
- 49
- 24
- 16
- 16
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.56 | ||
| Price to Tang. Book | 1.56 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.5 | ||
| EV to EBITDA | 124.43 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -0.17% | ||
| Return on Equity | 3.27% | ||
| Operating Margin | -0.29% | ||
Financial Summary
| Year End 31st Mar | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 213.08 | 273.2 | 255.16 | 304.06 | 337.22 | n/a | n/a | 15.37% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +127.06 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Genpharmasec Limited is an India-based company, which is engaged in the distribution of diagnostic pharma equipment and trading of securities. The Company’s segments include Pharmaceuticals, Trading in Securities, and Laboratory Testing. The Trading in Securities segment invests in the secondary securities market. The Company holds rights to the distribution of equipment, such as i-STAT Analyzers and its Cartridges, manufactured by Abbott Point of Care, USA, all over India. The i-STAT Analyzer is a blood analyzer used in Intensive Care Units (ICUs) of hospitals and provides test results in approximately 10 minutes. The Company’s wholly owned subsidiary includes M/s. Clinigenome India Private Limited.
Directors
- Ulhas Deosthale CFO (63)
- Snehal Aansodariya CCO
- Rajesh Sadhwani NED
- Sneha Sadhwani NED
- Yogesh Bhuva NID (29)
- Amisha Dani NID
- Nikhita Pais NID (27)
- Last Annual
- March 31st, 2025
- Last Interim
- June 30th, 2025
- Incorporated
- November 16th, 1992
- Public Since
- February 5th, 1996
- No. of Employees
- 10
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Bombay Stock Exchange- Shares in Issue
- 553,719,700
- Address
- Office No. 104 & 105 (1st Floor),, MUMBAI, 400101
- Web
- https://www.genpharmasec.com/
- Phone
- +91 8655550242
- Auditors
- ABHISHEK S TIWARI & ASSOCIATES.
Upcoming Events for 531592
Q3 2026 Genpharmasec Ltd Earnings Release
Similar to 531592
Adeshwar Meditex
Bombay Stock Exchange
ADS Diagnostic
Bombay Stock Exchange
Alan Scott Enterprises
Bombay Stock Exchange
Amkay Products
Bombay Stock Exchange
AVI Products India
Bombay Stock Exchange
FAQ
What is the Genpharmasec share price?
As of Today at 02:48 UTC, shares in Genpharmasec are trading at IN₹1.83. This share price information is delayed by 15 minutes.
How has the Genpharmasec share price performed this year?
Shares in Genpharmasec last closed at IN₹1.83 and the price had moved by -41.9% over the past 365 days. In terms of relative price strength the Genpharmasec share price has underperformed the S&P BSE 100 Index by -41.87% over the past year.
What are the analyst and broker recommendations for Genpharmasec?
There is no consensus recommendation for this security.
Find out moreWhat is the Genpharmasec dividend yield?
Genpharmasec does not currently pay a dividend.
Does Genpharmasec pay a dividend?
Genpharmasec does not currently pay a dividend.
When does Genpharmasec next pay dividends?
Genpharmasec does not currently pay a dividend.
How do I buy Genpharmasec shares?
To buy shares in Genpharmasec you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Genpharmasec?
As of the previous close price of IN₹1.83, shares in Genpharmasec had a market capitalisation of IN₹1.01bn.
Where are Genpharmasec shares listed?
Here are the trading details for Genpharmasec:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 531592
What kind of share is Genpharmasec?
Based on an overall assessment of its quality, value and momentum Genpharmasec is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Genpharmasec share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Genpharmasec share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Genpharmasec. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -15.17%.
As of the last closing price of IN₹1.83, shares in Genpharmasec were trading -16.65% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Genpharmasec PE Ratio?
The Genpharmasec PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹1.83.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Genpharmasec?
Genpharmasec's management team is headed by:
- Ulhas Deosthale - CFO
- Snehal Aansodariya - CCO
- Rajesh Sadhwani - NED
- Sneha Sadhwani - NED
- Yogesh Bhuva - NID
- Amisha Dani - NID
- Nikhita Pais - NID